Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Rationale and recruitment in the PARTNER trial

Dr Jean Abraham - University of Cambridge, Cambridge, UK

Rationale and recruitment in the PARTNER trial ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )

The role of axiliary node dissection in modern breast cancer surgery

Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy

The role of axiliary node dissection in modern breast cancer surgery ( Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy )

Anastrozole duration for post-menopausal breast cancer patients after 5 years...

Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria

Anastrozole duration for post-menopausal breast cancer patients after 5 years of endocrine therapy ( Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )

ER positive breast cancer: Screening for clinical variables to predict late...

Dr Ivana Sestak - Queen Mary University of London, London, UK

ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence ( Dr Ivana Sestak - Queen Mary University of London, London, UK )

Predicting late breast cancer recurrence with screening assays

Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK

Predicting late breast cancer recurrence with screening assays ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK )

Individualising treatment of axillary nodes in breast cancer

Prof Tari King - Brigham and Women’s Cancer Center, Boston, USA

Individualising treatment of axillary nodes in breast cancer ( Prof Tari King - Brigham and Women’s Cancer Center, Boston, USA )

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression...

Prof Gini Fleming - University of Chicago, Chicago, USA

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression via exemestane to tamoxifen alone ( Prof Gini Fleming - University of Chicago, Chicago, USA )

CDK 4/6 inhibitors for older women with HR-positive breast cancer

Harpreet Singh - FDA, USA

CDK 4/6 inhibitors for older women with HR-positive breast cancer ( Harpreet Singh - FDA, USA )

Talazoparib vs physicians choice for patients with mBRCA1 breast cancer

Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA

Talazoparib vs physicians choice for patients with mBRCA1 breast cancer ( Prof Jennifer Litton - MD Anderson Cancer Center, Houston, USA )

How can scalp-cooling reduce chemotherapy induced hair loss?

Richard Paxman - Paxman Coolers Ltd

How can scalp-cooling reduce chemotherapy induced hair loss? ( Richard Paxman - Paxman Coolers Ltd )

Acupuncture significantly reduces joint pain for breast cancer patients

Prof Dawn Hershman - Columbia University Medical Center, New York, NY

Acupuncture significantly reduces joint pain for breast cancer patients ( Prof Dawn Hershman - Columbia University Medical Center, New York, NY )

Phase III trial data supports current standard 12-month adjuvant trastuzumab...

Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland

Phase III trial data supports current standard 12-month adjuvant trastuzumab for HER2-positive breast cancer ( Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland )

More from ecancer